2006
DOI: 10.1002/cmdc.200500026
|View full text |Cite
|
Sign up to set email alerts
|

Current Developments in HIV Chemotherapy

Abstract: HIV infection is the leading cause of death worldwide and despite major advances in treatment, more new cases were diagnosed in 2004 than any previous year. Current treatment regimens are based on the use of two or more drugs from two or more classes of inhibitors termed highly active antiretroviral therapy (HAART). Although HAART is capable of suppressing viral loads to undetectable levels, problems of toxicity, patient adherence, and particularly the emergence of drug-resistant viruses continues to spur the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
44
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(44 citation statements)
references
References 100 publications
0
44
0
Order By: Relevance
“…Integrase is a viral protein of 32 kDa responsible for the insertion of newly reverse-transcribed doublestranded viral DNA into the host genome [48]. An IN inhibitor could offer improvements in selectivity, Ridley et al [50] reported that the sulfate group is critical for the anti-HIV-1 integrase activity of Lam-α 20-sulfate, because Lam-α showed no inhibition of HIV-1 integrase at concentrations up to 1.6 µM.…”
Section: Focus On Hiv Integrasementioning
confidence: 99%
“…Integrase is a viral protein of 32 kDa responsible for the insertion of newly reverse-transcribed doublestranded viral DNA into the host genome [48]. An IN inhibitor could offer improvements in selectivity, Ridley et al [50] reported that the sulfate group is critical for the anti-HIV-1 integrase activity of Lam-α 20-sulfate, because Lam-α showed no inhibition of HIV-1 integrase at concentrations up to 1.6 µM.…”
Section: Focus On Hiv Integrasementioning
confidence: 99%
“…Following the general procedure from 5-iodouracil 6 (1.55 g, 6.5 mmol) and after purification of the crude mixture by flash chromatography (CH 2 …”
Section: Methyl 5-deoxy-5-(24-dioxo-5-iodopyrimidin-1h-1-yl)-23-o-imentioning
confidence: 99%
“…The resulting mixture was purified by flash column chromatography on silica gel. The product was eluted with CH 2 . After evaporation of volatiles, the crude residue was purified by flash chromatography (CH 2 Cl 2 /MeOH 9:1).…”
Section: Methyl 5-deoxy-5-24-dioxo-5-[(2-trimethylsilyl)ethynyl]pyrmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the use of nucleoside antimetabolites also has the serious drawback that these agents may acquire drug resistance during clinical use. [10][11][12] To overcome this problem, the synthesis of diverse and structurally novel nucleoside derivatives is urgently needed in order to continue the search for new antitumor and antiviral agents.…”
Section: Introductionmentioning
confidence: 99%